For $499 a month, we'll provide a comprehensive medical examination, an Inbody diagnostics scan, a review and analysis of your bloodwork, and weekly injections administered on location by our providers
Tirzepatide : This injectable is a newer, dual-action drug that targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors, which enhances its effectiveness for weight loss
Here's what the research says, how to reconstitute it, and what real protocols look like
Beyond PARPis, multiple DDR kinases, including ATM, ATR, CHK1/2, WEE1, and DNA-dependent protein kinase catalytic subunit (DNA-PKcs), have emerged as therapeutic targets
We will discuss later the potential double whammy effect of patients on tamoxifen receiving CYP2D6 inhibitors and enzyme inducers simultaneously, a potentially disastrous combination